Use of recombinant glycoprotein antigens gB and gH for diagnosis of primary human cytomegalovirus infection during pregnancy

Journal of Medical Virology

Volumn 63, Issue 2, 2001, Pages 135-142

  Eggers, Maren ^a,b   Radsak, Klaus ^a   Enders, Gisela ^a,b,c   Reschke, Marko ^b,c  

^a Institut fur Virologie   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c Laboratory Prof G Enders and Partners   (Germany)

Author keywords

Glycoprotein specific antibody response; HCMV; Pregnancy; Primary infection

Indexed keywords

GLYCOPROTEIN; NEUTRALIZING ANTIBODY;

ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; CYTOMEGALOVIRUS INFECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; MOLECULAR CLONING; PREGNANCY; PREGNANCY COMPLICATION; RELIABILITY; SEROCONVERSION; VIRUS INFECTION; VIRUS REACTIVATION; VIRUS TRANSMISSION;

ANTIBODIES, VIRAL; ANTIGENS, VIRAL; BIOLOGICAL MARKERS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; EPITOPES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN G; NEUTRALIZATION TESTS; PHOSPHOPROTEINS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; RECOMBINANT PROTEINS; VIRAL ENVELOPE PROTEINS; VIRAL MATRIX PROTEINS;

HUMAN HERPESVIRUS 5;

EID: 0035122285     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-9071(20000201)63:2<135::AID-JMV1008>3.0.CO;2-P     Document Type: Article

References (44)

1. A canarypox vector expressing cytomegalovirus (CMV) glycoprotein B primes for antibody responses to a live attenuated HCMV vaccine (Towne)
2. Congenital and perinatal cytomegalovirus infections
3. Complement-independent neutralizing monoclonal antibody with differential reactivity for strains of human cytomegalovirus
4. Recognition of compartmentalized intracellular analogs of glycoprotein H of human cytomegalovirus
5. Antiviral antibody responses and intrauterine trans-mission after primary maternal cytomegalovirus infection
6. Symptomatic congenital cytomegalovirus infection in infants born to mothers with preexisting immunity to cytomegalovirus
7. Cell surface expression of human cytomegalovirus (HCMV) gp55-116 (gB): Use of HCMV-recombinant vaccinia virus-infected cells in analysis of the human neutralizing antibody response
8. Neonatal screening for congenital cytomegalovirus infections
9. Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains
10. Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169
11. Detection of human cytomegalovirus in urine samples by cell culture, early antigen assay and polymerase chain reaction
12. An enzyme linked immunoassay using recombinant antigens for differentiation of primary from secondary or past CMV infections in pregnancy
13. Congenital cytomegalovirus infection
14. Differentiation between acute primary and recurrent human cytomegalovirus infection in pregnancy using a microneutralization assay
15. Combination of microneutralization and avidity assays: Improved diagnosis of recent primary HCMV-infection in single serum sample of second trimester pregnancy
16. Viral infections of the fetus and neonate, other than rubella. Specific infections 3 cytomegalovirus
17. Progressive and fluctuating sensorineural hearing loss in children with asymptomatic congenital cytomegalovirus infection
18. Maternal age and congenital cytomegalovirus infection: Screening of two diverse newborn populations, 1980-1990
19. Effects of antigen dose and immunization regimens on antibody responses to a cytomegalovirus glycoprotein B subunit vaccine
20. Specific cell-mediated immune defect in active cytomegalovirus infection of young children and their mothers
21. The two major structural phosphoproteins (pp65 and pp150) of human cytomegalovirus and their antigenic properties
22. Strain-specific neutralization of human cytomegalovirus isolates by human sera
23. Distribution of linear antigenic sites on glycoprotein gp55 of human cytomegalovirus
24. An ELISA using recombinant proteins for the detection of neutralizing antibodies against human cytomegalovirus
25. Large scale screening of human sera with cytomegalovirus recombinant antigens
26. Humoral immune response to human cytomegalovirus proteins: A brief review
27. Human cytomegalovirus structural proteins: Immune reaction against pp150 synthetic peptides
28. Humoral immune response to proteins of human cytomegalovirus latency-associated transcripts
29. A novel Western blot test containing both viral and recombinant proteins for anticytomegalovirus immunoglobulin M detection
30. Mapping of serologically relevant regions of human cytomegalovirus phosphoprotein pp150 using synthetic peptides
31. A subunit cytomegalovirus vaccine based on recombinant envelope glycoprotein B and a new adjuvant
32. Vaccination against cytomegalovirus, the changeling demon
33. Th1-type immunity is incompatible with successful pregnancy
34. Constitutive expression of human cytomegalovirus (HCMV) glycoprotein gpUL75(gH) in astrocytoma cells: A study of the humoral immune response
35. The humoral immune response against human cytomegalovirus is characterized by a delayed synthesis of glycoprotein-specific antibodies
36. Characterization of major antigenic region on gp 55 of human cytomegalovirus
37. Human cytomegalovirus structural proteins
38. Cytomegalovirus
39. An early marker of fetal infection after primary cytomegalovirus infection in pregnancy
40. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications
41. The dominant linear neutralizing antibody-binding site of glycoprotein gp86 of human cytomegalovirus is strain specific
42. Glycoprotein H of human cytomegalovirus is a major antigen for the neutralizing humoral immune response
43. Early serodiagnosis of acute human cytomegalovirus infection by enzyme-linked immunosorbent assay using recombinant antigens